Chargement de la fiche…
Chargement de la fiche…
Praticien hospitalier
Photo : Chabe01, CC BY-SA 4.0, Wikimedia Commons
Dans les médias
Vous êtes Dr Xavier Mariette ? Présentation, expertises, actes, site du cabinet : faites de cette fiche la page de votre cabinet.
Configurer votre fiche gratuitement →Dr Xavier Mariette est rhumatologue à Le Kremlin-Bicêtre (94275). Il consulte à GHU APHP UPS SITE KREMLIN BICETRE APHP, 78 Avenue DU GENERAL LECLERC, 94275 Le Kremlin-Bicêtre.
Consulter
GHU APHP UPS SITE KREMLIN BICETRE APHP
Dr Xavier Mariette, c'est vous ?
Faites de cette fiche la page de votre cabinet.
78 Avenue DU GENERAL LECLERC, 94275 Le Kremlin-Bicêtre
Hospitalier
Pour aller plus loin
Remboursement
Pratique
Thèmes de publication
Domaines déduits des publications référencées sur PubMed.
Faits issus de registres publics et des déclarations du praticien — aucun classement.
Rhumatologie (SM) — Diplôme d'études spécialisées
DE Docteur en médecine · Cancérologie (C) — Capacité / certificat d'études spéciales
Les plus citées
2025Nature reviews. Rheumatology92 citations
2023 International Rome consensus for the nomenclature of Sjögren disease
2025The Lancet. Rheumatology55 citations
CAR T-cell therapy in autoimmune diseases: where are we and where are we going?
2025Annals of the rheumatic diseases25 citations
Primary Sjögren's Disease: a review of unmet need, outcome measures, therapeutic advances and health economic impacts. Lessons from the NEw Clinical Endpoints in primary Sjögren's Syndrome: an Interventional Trial based on stratifYing patients (NECESSITY) Innovative Health Initiative (IHI)
Contenus publics où le nom du praticien apparaît (YouTube, Google Actualités).
En bref
Dr Xavier Mariette consulte à GHU APHP UPS SITE KREMLIN BICETRE APHP, 78 Avenue DU GENERAL LECLERC, 94275 Le Kremlin-Bicêtre. Adresses issues de l'Annuaire Santé (ANS).
Par téléphone au 01 45 21 21 21 (numéro publié à l'Annuaire Santé). Un lien de recherche Doctolib est proposé sur cette page : si le praticien y est inscrit, son profil figure normalement parmi les résultats.
Identité, diplômes et lieux d'exercice : Annuaire Santé (ANS, licence ouverte). Conventionnement et carte Vitale : Assurance Maladie. Publications : bases scientifiques publiques (PubMed, HAL, OpenAlex), affichées seulement si le nom du praticien figure parmi les auteurs. Le praticien peut corriger sa fiche ou en demander le retrait à tout moment ; en cas d'homonymie, signalez-le.
Autour du cabinet
Rhumatologues à Le Kremlin-Bicêtre →Rhumatologues en Val-de-Marne (94) →
Vous pouvez aussi demander le retrait de la fiche.
Aperçu de votre présentation
Rhumatologue à Le Kremlin-Bicêtre, j'accompagne…
Exemple : vous choisissez vos propres domaines.
Ianalumab for the Treatment of Patients with Sjögren's Disease
2026Rheumatology (Oxford, England)PubMed
Characteristics of patients with isolated anti-Ku antibodies
2026Proceedings of the National Academy of Sciences of the United States of AmericaPubMed
Loss of epitranscriptomic mitochondrial RNA surveillance drives epithelial type I interferon and inflammation in autoimmunity
2026The Journal of experimental medicinePubMed
Humans homozygous for rare or common hypomorphic IL23R variants are prone to tuberculosis
2026RMD openPubMed
Characteristics and outcomes of anti-Ku antibody-associated interstitial lung disease: a retrospective study of 60 patients
2026Rheumatology (Oxford, England)PubMed
Stability and prognostic value of B-cell markers in primary SS: results from the French ASSESS cohort
2026Rheumatology (Oxford, England)PubMed
Long-term outcomes and prognosis of mixed cryoglobulinaemia: a European multicentre study of 1294 patients
2026Presse medicale (Paris, France : 1983)PubMed
Immune checkpoint inhibitor-induced joint involvement
2026Presse medicale (Paris, France : 1983)PubMed
Sicca induced by immune checkpoint inhibitors
2026JCI insightPubMed
Levels of circulating kidney injury markers and IL-10 identify non-critically ill patients with COVID-19 at risk of death
2026Methods in molecular biology (Clifton, N.J.)PubMed
Macrophage Cell Culture and Characterization by Serum Human AB in Health and Disease
2026Joint bone spinePubMed
Lessons from organoid engineering for rheumatic disease
2025Annals of the rheumatic diseasesPubMed
Variants in the DDX6-CXCR5 autoimmune disease risk locus influence the regulatory network in immune cells and salivary gland
2025Annals of the rheumatic diseasesPubMed
Pulmonary arterial hypertension in adults with Still's disease: another pulmonary manifestation associated with HLA-DRB1*15
2025RMD openPubMed
Cluster analysis identifies three clinical patterns of patients with systemic autoimmune diseases and anti-Ku antibodies
2025The Lancet. RheumatologyPubMed
CAR T-cell therapy in autoimmune diseases: where are we and where are we going?
2026Journal of the National Cancer InstitutePubMed
Associations between breast cancer and rheumatoid arthritis among older-age women in the United States
2026The Lancet. RheumatologyPubMed
Aligning approaches to rheumatoid arthritis drug development: a comparison of FDA and EMA guidance
2026RMD openPubMed
PD1(+) TIGIT(+) CD4(+) T cells predict response to anti-TNF in rheumatoid arthritis and spondyloarthritis
2026JNCI cancer spectrumPubMed
Cancer risk associated with abatacept among older individuals with rheumatoid arthritis in the United States
2026RMD openPubMed
Birth length and perinatal exposures and rheumatoid arthritis risk in the E3N cohort
2025RMD openPubMed
Early-life animal and farming exposures and the risk of rheumatoid arthritis: findings from the E3N French cohort study
2025The Lancet. RheumatologyPubMed
Effect of a 1-month methotrexate delay on pneumococcal vaccine immunogenicity and disease control in patients with early rheumatoid arthritis (VACIMRA): an open-label randomised trial
2025Joint bone spinePubMed
Risk of cancer in patients with rheumatoid arthritis under tocilizumab: Data from the French national registry REGATE
2025Rheumatology (Oxford, England)PubMed
Cancer risk of Janus kinase inhibitors and biological disease-modifying antirheumatic drugs among older Americans with rheumatoid arthritis
2025BMJ openPubMed
Abatacept versus tocilizumab for the treatment of rheumatoid arthritis in TNF inhibitor inadequate responders: study protocol of the SUNSTAR randomised controlled open-label superiority trial
2026JNCI cancer spectrumPubMed
Cancer risk associated with abatacept among older individuals with rheumatoid arthritis in the United States
2026Annals of the rheumatic diseasesPubMed
Transcriptomic stratification predicts response to rituximab, abatacept, or the association of hydroxychloroquine and leflunomide in 3 randomised controlled clinical trials of Sjögren's disease
2025Joint bone spinePubMed
Risk of cancer in patients with rheumatoid arthritis under tocilizumab: Data from the French national registry REGATE
2025BMJ openPubMed
Abatacept versus tocilizumab for the treatment of rheumatoid arthritis in TNF inhibitor inadequate responders: study protocol of the SUNSTAR randomised controlled open-label superiority trial
2026Seminars in arthritis and rheumatismPubMed
Juvenile-onset mixed connective tissue disease: A multicenter retrospective cohort study
2025RMD openPubMed
Unravelling IPAF, VEDOSS and connective tissue diseases classifications through the mixed connective tissue disease spectrum
2025Journal of autoimmunityPubMed
Treatment of mixed connective tissue disease: A multicenter retrospective study
2026Annals of the rheumatic diseasesPubMed
Transcriptomic stratification predicts response to rituximab, abatacept, or the association of hydroxychloroquine and leflunomide in 3 randomised controlled clinical trials of Sjögren's disease
2025The Lancet. RheumatologyPubMed
Effect of a 1-month methotrexate delay on pneumococcal vaccine immunogenicity and disease control in patients with early rheumatoid arthritis (VACIMRA): an open-label randomised trial
2026 · Article
Loss of epitranscriptomic mitochondrial RNA surveillance drives epithelial type I interferon and inflammation in autoimmunity
2026 · Article
Humans homozygous for rare or common hypomorphic IL23R variants are prone to tuberculosis
2026 · Article
Stability and prognostic value of B-cell markers in primary Sjögren’s syndrome: results from the French ASSESS cohort
2026 · Article
The SjD Map: an interactive pathway tour into Sjögren’s disease signalling mechanisms
2026 · Article
Juvenile-onset mixed connective tissue disease: A multicenter retrospective cohort study
2026 · Article
Levels of circulating kidney injury markers and IL-10 identify non-critically ill patients with COVID-19 at risk of death
2026 · Article
A genetic variant of BAFF is associated with the risk of lymphoma in Sjögren disease
2025 · Article
Machine learning to classify the focus score and Sjögren's disease using digitalised salivary gland biopsies: a retrospective cohort study
Publications affichées uniquement lorsque le nom du praticien figure parmi les auteurs. Une erreur d'homonymie ? Signalez-la depuis le lien en bas de page.
2024 · doctorant : Loïc Meudec
Développement d'organoïdes de glande salivaire dans la maladie de Sjögren : un outil innovant pour l'étude de la maladie et l'identification de nouvelles thérapies ciblées
2020 · doctorant : Élodie Rivière
Rôle des cellules épithéliales salivaires au cours du Syndrome de Sjögren primitif
2018 · doctorant : Samuel Bitoun
Mise au point de modèles animaux pour étudier la physiopathologie de la polyarthrite rhumatoïde et le rôle du méthotrexate dans la tolérisation
2015 · doctorant : Gaetane Nocturne
Mécanismes de la lymphomagenèse au cours des maladies auto-immunes : rôle de la génétique, de l'activité de la maladie et des traitements
2012 · doctorant : Nicolas Gestermann
Causes et conséquences de l’activation de l’interféron de type I dans les maladies auto-immunes. Étude dans le modèle du syndrome de Sjögren
2009 · doctorant : Marc Ittah
Lien entre l'immunité innée, la cytokine BAFF (B-cell activating factor of TNF family) et l'auto-immunité